Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-FLU: Influenza vaccination strategies in solid-organ transplant recipients
2019-001974-27Phase 2Active
- Sponsor
- Lausanne University Hospital
- Start
- Aug 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of Fluzone Trivalent in influenza, sponsored by Lausanne University Hospital. Primary endpoint: Seroconversion rate at day 28. Started Aug 2019; status: active.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2019-001974-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001974-27.